Global Medicare · Ovarian Program
Before considering egg donation, explore another possibility.
A specialist evaluation pathway for women seeking another review of ovarian-factor fertility concerns, including low ovarian reserve, poor ovarian response, previous unsuccessful IVF or advanced reproductive age.
Global Medicare provides initial orientation and coordination. Clinical assessment, treatment decisions and research eligibility remain with the authorised medical and research teams.
Start with your situation
Does this sound familiar?
Some fertility journeys reach a point where another specialist review may help clarify what to consider next.
These situations do not establish a diagnosis, treatment recommendation or research eligibility.
A decision worth reviewing carefully
Before moving to egg donation, your case may deserve another specialist review.
For some women, egg donation may ultimately become the most appropriate option. A specialist evaluation can help review whether additional clinical possibilities should be considered before making that decision.
No outcome is guaranteed. The purpose of the pathway is specialist evaluation and informed decision-making.
The Ovarian Program
From your first question to specialist evaluation.
A structured pathway that keeps orientation, clinical decision-making and research clearly separated.
Your situation
Tell us what has led you to seek another review.
Initial orientation
Global Medicare organises the appropriate next step.
Specialist assessment
The clinical team reviews the relevant medical information.
Clinical decision
Medical decisions remain independent from research participation.
Research when applicable
The research pathway is considered only when appropriate.
Science
The ovarian research context.
The ovarian research framework at IVF Baden-Baden compares two autologous preparations: Standard-PRP and IAS.
The clinical choice between Standard-PRP and IAS is made independently from participation in research. Neither option is presented as superior on this basis.
IAS is an autologous preparation with an additional processing step. It should not be described as purified exosome therapy.
Clinical & Research Centre
Baden-Baden
Specialist evaluation within an established clinical pathway.
The ovarian observational study is conducted at IVF Baden-Baden in Germany.
Clinical care and research participation are separate. Participation in the Ovarian Program does not guarantee participation in the research study.
ExoRegenOvo
Study 02-REGEN-AR02-REGEN-AR is the ovarian observational study conducted at IVF Baden-Baden. It compares outcomes observed in patients receiving Standard-PRP or IAS within the clinical pathway.
ExoRegenOvo is used here as the ovarian program/project name. The current observational study identifier remains 02-REGEN-AR. This information does not confirm research eligibility.
Initial orientation
Tell us a little about your situation.
A few general questions can help organise the next step towards a specialist review.
Important questions
Clear information before your next step.
Understand where general orientation ends and medical or research assessment begins.
Does this page confirm whether I am eligible for 02-REGEN-AR?
Can Global Medicare interpret my AMH or AFC results?
Is IAS considered better than Standard-PRP?
Does participation in research guarantee a health benefit?
What can the Global Medicare Patient Assistant help with?
Your next step
A specialist review starts with your story.
If your fertility journey involves ovarian reserve, ovarian response, previous IVF or an important decision about what to do next, Global Medicare can help organise the initial orientation pathway.